Géraldine Rigou

Statistics

Publications

Citations

494

H-Index

Active since

2013

Affiliations

Genfit (France)(Current)

Inserm

Institut du Thorax

Institut Pasteur de Lille

Université de Lille

Géraldine Rigou is an author at Genfit (France) specializing in molecular pharmacology, pharmacology, and peroxisome proliferator-activated receptor alpha (ppar-alpha) signaling.

Publications per year

2013–2014

Publications

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Bart Staels, A. Rubenstrunk, Benoît Noël et al. · Hepatology · 2013 · 405 citations

Medicine, Pharmacology, Hepatology +15

The Identification of Naturally Occurring Neoruscogenin as a Bioavailable, Potent, and High-Affinity Agonist of the Nuclear Receptor RORα (NR1F1)

Stéphane Helleboid, Christian Haug, Kai Lamottke et al. · SLAS DISCOVERY · 2013 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in <i>db</i> / <i>db</i> mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects

Rémy Hanf, Lesley J. Millatt, Bertrand Cariou et al. · Diabetes and Vascular Disease Research · 2014 · 37 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–3 of 3